Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
3.530
+0.340 (10.66%)
At close: Jun 27, 2025, 4:00 PM
3.500
-0.030 (-0.85%)
After-hours: Jun 27, 2025, 7:47 PM EDT
Immuneering Employees
Immuneering had 66 employees as of December 31, 2024. The number of employees decreased by 2 or -2.94% compared to the previous year.
Employees
66
Change (1Y)
-2
Growth (1Y)
-2.94%
Revenue / Employee
n/a
Profits / Employee
-$935,984
Market Cap
127.03M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 66 | -2 | -2.94% |
| Dec 31, 2023 | 68 | -5 | -6.85% |
| Dec 31, 2022 | 73 | 9 | 14.06% |
| Dec 31, 2021 | 64 | 38 | 146.15% |
| Dec 31, 2020 | 26 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
IMRX News
- 11 days ago - Immuneering Reports Positive Overall Survival Data for Atebimetinib (IMM-1-104) from Ongoing Phase 2a Trial in First-Line Pancreatic Cancer Patients - GlobeNewsWire
- 12 days ago - Immuneering to Provide Updates from Phase 2a Clinical Trial of IMM-1-104 in First-Line Pancreatic Cancer Patients on Tuesday, June 17, 2025 - GlobeNewsWire
- 4 weeks ago - Immuneering to Present at the Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Immuneering Reports First Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 3 months ago - Immuneering Corporation Announces Grant of Inducement Award - GlobeNewsWire
- 3 months ago - Immuneering Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Immuneering Names Dr. Igor Matushansky as Chief Medical Officer - GlobeNewsWire